These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 38449865)

  • 1. Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence.
    Federico L; Malone B; Tennøe S; Chaban V; Osen JR; Gainullin M; Smorodina E; Kared H; Akbar R; Greiff V; Stratford R; Clancy T; Munthe LA
    Front Immunol; 2024; 15():1377041. PubMed ID: 38449865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence.
    Federico L; Malone B; Tennøe S; Chaban V; Osen JR; Gainullin M; Smorodina E; Kared H; Akbar R; Greiff V; Stratford R; Clancy T; Munthe LA
    Front Immunol; 2023; 14():1265044. PubMed ID: 38045681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
    Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
    EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
    Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
    Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide B Cell, CD4
    Prakash S; Srivastava R; Coulon PG; Dhanushkodi NR; Chentoufi AA; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Buchmeier MJ; Bouziane M; Nesburn AB; Kuppermann BD; BenMohamed L
    J Immunol; 2021 Jun; 206(11):2566-2582. PubMed ID: 33911008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of promising CD8 and CD4 T cell epitopes for peptide vaccine formulation against SARS-CoV-2.
    Chakraborty S; Deb B; Nath D; Monoswita D
    Arch Microbiol; 2022 Apr; 204(5):242. PubMed ID: 35380253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HLA-A2 restricted CD8
    Deng J; Pan J; Qiu M; Mao L; Wang Z; Zhu G; Gao L; Su J; Hu Y; Luo OJ; Chen G; Wang P
    J Leukoc Biol; 2021 Dec; 110(6):1171-1180. PubMed ID: 34231935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodominant SARS-CoV-2-specific CD4
    Ning J; Wang Q; Chen Y; He T; Zhang F; Chen X; Shi L; Zhai A; Li B; Wu C
    J Med Virol; 2023 Apr; 95(4):e28743. PubMed ID: 37185843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain:
    Chukwudozie OS; Chukwuanukwu RC; Iroanya OO; Eze DM; Duru VC; Dele-Alimi TO; Kehinde BD; Bankole TT; Obi PC; Okinedo EU
    J Immunol Res; 2020; 2020():2837670. PubMed ID: 32964056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.
    Carter B; Huang P; Liu G; Liang Y; Lin PJC; Peng BH; McKay LGA; Dimitrakakis A; Hsu J; Tat V; Saenkham-Huntsinger P; Chen J; Kaseke C; Gaiha GD; Xu Q; Griffiths A; Tam YK; Tseng CK; Gifford DK
    Front Immunol; 2023; 14():1135815. PubMed ID: 36969239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8
    Jin X; Ding Y; Sun S; Wang X; Zhou Z; Liu X; Li M; Chen X; Shen A; Wu Y; Liu B; Zhang J; Li J; Yang Y; Qiu H; Shen C; He Y; Zhao G
    Cell Mol Immunol; 2021 Dec; 18(12):2588-2608. PubMed ID: 34728796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs.
    Pan K; Chiu Y; Huang E; Chen M; Wang J; Lai I; Singh S; Shaw RM; MacCoss MJ; Yee C
    Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34725257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-specific CD8
    Rowntree LC; Petersen J; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Wheatley AK; Kent SJ; Rossjohn J; Kedzierska K; Nguyen TH
    Immunol Cell Biol; 2021 Oct; 99(9):990-1000. PubMed ID: 34086357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
    Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
    Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum:
    Michel-Todó L; Reche PA; Bigey P; Pinazo MJ; Gascón J; Alonso-Padilla J
    Front Immunol; 2019; 10():3124. PubMed ID: 32082303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: Cross-reactive humoral and CD4
    Martel F; Cuervo-Rojas J; Ángel J; Ariza B; González JM; Ramírez-Santana C; Acosta-Ampudia Y; Murcia-Soriano L; Montoya N; Cardozo-Romero CC; Valderrama-Beltrán SL; Cepeda M; Castellanos JC; Gómez-Restrepo C; Perdomo-Celis F; Gazquez A; Dickson A; Brien JD; Mateus J; Grifoni A; Sette A; Weiskopf D; Franco MA
    Front Immunol; 2023; 14():1274753. PubMed ID: 37662943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.